research of physician-scientists, with the goal of empowering medical scientists to expand the boundaries of scientific discovery, develop new medical therapies, and alleviate human suffering caused by diseases. Under Dr. Feldman’s leadership, the Taubman Institute funded senior-level physician-scientists in a broad spectrum of diseases but with special attention on adult and childhood cancer, cardiovascular and metabolic diseases, and neurological conditions such as ALS, Alzheimer’s disease and the diabetic neuropathy. The Institute’s funding focused on supporting “translational” research; the kind that transforms laboratory discoveries into treatments for patients. She also established an Emerging Scholars program to support promising early-career physician scientists at the Taubman Institute, which has provided unencumbered seed funding to over 20 junior investigators, with an emphasis on improving the diversity of the clinician-scientist workforce. Dr. Feldman served as Director of the Taubman Institute for 10 years and had remarkable success in fulfilling the founder’s vision. It now supports the work of over 40 of the University’s most prominent and promising clinician-scientists, almost half of which are in the Emerging Scholar Program she began. Notably, Taubman Institute funding has also led to multiple human clinical trials in cancer therapy, autoimmune diseases, and neurological diseases, including Dr. Feldman’s own first human clinical trial of a stem cell treatment for ALS noted above. Stem cell initiative In addition to her role in academia, Dr. Feldman has been a leading spokesperson on issues related to medical science to the general community, frequently appearing in public and in the media. She has been a true ambassador for medical science. This was never more evident than the role she and the Taubman Institute played in the 2008 election when Michigan voters passed a constitutional amendment easing restrictions on embryonic stem cell research. Appearing on numerous television and radio programs, in newspaper articles and public speaking engagements, she was one of the main educators on the value of such research in the understanding and treatment of diseases. In the final days before the election, Dr. Feldman spoke alongside former President Bill Clinton at a large educational rally. In the following year, Dr. Feldman announced the formation of the Consortium of Stem Cell Therapies at the Taubman Institute, the first facility to produce embryonic stem cell lines in Michigan and one of only a handful in the nation. Center for RNA Biomedicine at the University of Michigan In the fall of 2015, under the leadership of